Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
14%
Ph not_applicable
6
86%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(1)
Other(4)

Detailed Status

unknown4
Enrolling by invitation1
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (14.3%)
N/A6 (85.7%)

Trials by Status

enrolling_by_invitation114%
recruiting114%
completed114%
unknown457%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7